Article in business/trade/industry journal

• Søiland, Håvard; Janssen, Emiel; Helland, Thomas et al. (2022). Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study. (external link)

Academic article

• Peccatori, Fedro Alessandro; Codacci-Pisanelli, Giovanni; Mellgren, Gunnar et al. (2020). First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: A case study. (external link)
• Helland, Thomas; Hagen, Kari Britt; Haugstøyl, Martha Eimstad et al. (2019). Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. (external link)
• Helland, Thomas; Henne, Nina; Bifulco, Ersilia et al. (2017). Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. (external link)
• Johansson, Harriet; Gandini, Sara; Serrano, Davide et al. (2016). A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen. (external link)
• Helland, Thomas; Gjerde, Jennifer; Dankel, Simon N et al. (2015). The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells. (external link)
• Christensen, Monika; Fenne, Ingvild Sveinsgjerd; Nordbø, Yngve et al. (2015). Novel inflammatory biomarkers in primary hyperparathyroidism. (external link)
• Christensen, Monika; Fenne, Ingvild Sveinsgjerd; Flågeng, Marianne Hauglid et al. (2014). Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells. (external link)
• Hagen, Kari Britt; Aas, Turid; Lode, Kirsten et al. (2014). Illness uncertainty in breast cancer patients: Validation of the 5-item short form of the Mishel Uncertainty in Illness Scale. (external link)
• Serrano, Davide; Lazzeroni, Matteo; Gandini, Sara et al. (2013). A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. (external link)
• Lien, Ernst Asbjørn; Søiland, Håvard; Lundgren, Steinar et al. (2013). Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment. (external link)
• Hoang, Tuyen; Fenne, Ingvild Sveinsgjerd; Madsen, Andre Greger et al. (2013). cAMP response element-binding protein interacts with and stimulates the proteasomal degradation of the nuclear receptor coactivator GRIP1. (external link)
• Christensen, Monika; Apalset, Ellen M; Nordbø, Yngve et al. (2013). 1,25-dihydroxyvitamin D and the vitamin D receptor gene polymorphism apa1 influence bone mineral density in primary hyperparathyroidism. (external link)
• Christensen, Monika; Pedersen, Eva Kristine Ringdal; Nordbø, Yngve et al. (2012). Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. (external link)
• Gjerde, Jennifer; Gandini, Sara; Guerrieri-Gonzaga, Aliana et al. (2012). Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide. (external link)
• Moi, Line Leonore Haugan; Flågeng, Marianne Hauglid; Gjerde, Jennifer et al. (2012). Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. (external link)
• Decensi, Andrea; Guerrieri-Gonzaga, Aliana; Gandini, Sara et al. (2011). Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. (external link)
• Methlie, Paal; Husebye, Eystein Sverre; Hustad, Simon Steinar et al. (2011). Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. (external link)
• Christensen, Monika; Dankel, Simon E Nitter; Nordbø, Yngve et al. (2011). Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue. (external link)
• Christensen, Monika; Lien, Ernst Asbjørn; Hustad, Simon Steinar et al. (2010). Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. (external link)
• Moi, Line Leonore Haugan; Flågeng, Marianne Hauglid; Gandini, Sara et al. (2010). Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue. (external link)
• Gjerde, Jennifer; Geisler, Jürgen; Lundgren, Steinar et al. (2010). Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer. (external link)
• Bonanni, B; Serrano, D; Gandini, S et al. (2009). Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia. (external link)
• Decensi, Andrea; Robertson, Chris; Guerrieri-Gonzaga, Aliana et al. (2009). Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. (external link)
• Lash, Timothy L; Lien, Ernst Asbjørn; Sørensen, Henrik Toft et al. (2009). Genotype-guided tamoxifen therapy: time to pause for reflection?. (external link)
• Flageng, MH; Hauglid, Marianne; Moi, Line Leonore Haugan et al. (2009). Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. (external link)
• Karimian, Elham; Chagin, Andrei S; Gjerde, Jennifer Fernandez et al. (2008). Tamoxifen impairs both longitudinal and cortical bone growth in young male rats. (external link)
• Fenne, Ingvild Sveinsgjerd; Hoang, Tuyen; Hauglid, Marianne et al. (2008). Recruitment of coactivator glucocorticoid receptor interacting protein 1 to an estrogen receptor transcription complex is regulated by the 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase. (external link)
• Gjerde, Jennifer Fernandez; Hauglid, Marianne; Hauglid, M et al. (2008). Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. (external link)
• Gjerde, Jennifer; Geisler, Jurgen; Lundgren, Steinar et al. (2007). A study of association between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferae 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady sate tamoxifen treatment. (external link)
• Schjøtt, Jan; Gjerde, Jennifer; Kisanga, Elton Richard et al. (2006). Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats. (external link)
• Geisler, J; Lønning, Per Eystein; Krag, LE et al. (2006). Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study. (external link)
• Kisanga, Elton Richard; Mellgren, Gunnar; Lien, Ernst Asbjørn (2005). Excretion of hydroxylated metabolites of tamoxifen in human bile and urine. (external link)
• Kisanga, Elton Richard; Moi, Line Leonore Haugan; Gjerde, Jennifer et al. (2005). Induction of hepatic drug-metabolising enzymes and tamoxifen metabolite profile in relation to administration route during low-dose treatment in nude rats. (external link)
• Gjerde, Jennifer Fernandez; Kisanga, Elton Richard; Hauglid, Marianne et al. (2005). Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry. (external link)
• Holm, Pål Ivar; Bleie, Øyvind; Ueland, Per Magne et al. (2004). Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. (external link)
• Hoang, Tuyen; Fenne, Ingvild Sveinsgjerd; Cook, Carol Ann et al. (2004). cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. (external link)
• Hustad, Simon Steinar; Nedrebø, Bjørn Gunnar; Ueland, Per Magne et al. (2004). Phenotypic expression of the methylenetetrahydrofolate reductase 677C->T polymorphism and flavine cofactor availability in thyroid dysfunction. (external link)
• Kisanga, Elton Richard; Gjerde, Jennifer; Guerrieri-gonzaga, Aliana et al. (2004). Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in randomized preoperative trial. (external link)
• Bonanni, B; Johansson, H; Gandini, S et al. (2003). Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healty women. (external link)
• Nedrebø, Bjørn Gunnar; Hustad, Steinar; Schneede, Jørn et al. (2003). Homocysteine and its relations to B-vitamins and smoking in graves' disease before and after treatment. (external link)
• Holm, Pål Ivar; Ueland, Per Magne; Kvalheim, Gry et al. (2003). Determination of choline, betaine, and dimethylglycine in plasma by a high-troughput metod based on normal-phase chromatography-tandem mass spectrometry. (external link)
• Kisanga, Elton Richard; Gjerde, Jennifer; Schjøtt, Jan et al. (2003). Tamoxifen administration and metabolism in nude mice and nude rats. (external link)
• Mellgren, Gunnar; Børud, Bente; Hoang, Tuyen Thi Van et al. (2003). Characterization of receptor-interacting protein RIP140 in the regulation of SF-1 responsive target genes. (external link)
• Decensi, A; Robertson, C; Viale, G et al. (2003). A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. (external link)
• Mellgren, Gunnar; Holm, Pål Ivar; Lien, Ernst Asbjørn et al. (2002). Tyreotoksisk periodisk paralyse - en uvanlig komplikasjon ved hypertyreose. (external link)
• Nedrebø, Bjørn G; Holm, Pål Ivar; Uhlving, Sverre et al. (2002). Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. (external link)
• Nedrebø, Bjørn G; Nygård, Ottar; Ueland, Per Magne et al. (2001). Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. (external link)
• Guerrieri-Gonzaga, A; Baglietto, L; Johansson, H et al. (2001). Correlation between tamoxifen elimination and biomarker recovery in a primary prevention trial. (external link)
• Ulvik, Arve; Evensen, Espen Thiis; Lien, Ernst Asbjørn et al. (2001). Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. (external link)
• Bonanni, B; Johansson, H; Gandini, S et al. (2001). Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. (external link)
• Lien, Ernst Asbjørn; Nedrebø, Bjørn Gunnar; Varhaug, Jan Erik et al. (2000). Plasma total homocysteine levels during short-term iatrogenic hypothyreoidism. (external link)
• Lien, Ernst Asbjørn; Lønning, Per Eystein (2000). Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy. (external link)
• Lien, Ernst Asbjørn; Lønning, Per Eystein (2000). Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy. (external link)
• Decensi, A; Gandini, S; Guerrieri-Gonzaga, A et al. (1999). Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction. (external link)
• Anker, Gun Birgitta; Refsum, Helga; Ueland, Per Magne et al. (1999). Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients. (external link)
• Anker, Gun Birgitta; Refsum, Helga; Ueland, Per Magne et al. (1999). Influence of aromatase inhibitors on plasma total homocysteine levels in postmenopausal breast cancer patients. (external link)
• Love, RR; Anker, Gun Birgitta; Yang, Y et al. (1999). Serum homocysteine levels in postmenopausal breast cancer patients treated with tamoxifen. (external link)
• Anker, Gun Birgitta; Aakvaag, Asbjørn; Lønning, Per Eystein et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
• Nedrebø, B.G.; Ericsson, U.-B.; Nygård, Ottar et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
• Nedrebø, B.G.; Ericsson, U.-B.; Nygård, Ottar et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
• Nedrebø, B.G.; Ericsson, U.-B.; Nygård, Ottar et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
• Anker, Gun Birgitta; Lønning, Per Eystein; Aakvaag, Asbjørn et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
• Nedrebø, B.G.; Ericsson, U.-B.; Nygård, Ottar et al. (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. (external link)
• Anker, Gun Birgitta; Lønning, Per Eystein; Aakvaag, Asbjørn et al. (1998). Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. (external link)
• Lien, Ernst Asbjørn; Overå, O. (1997). Treatment of small cell lung cancer (SCLC) with high dose tamoxifen in combination with epirubicin, cyclophosphamide and oncovin. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgitta; Lønning, Per Eystein et al. (1997). Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgutta; Lønning, Per Eystein et al. (1997). Effects of hormones on the plasma level of the atherogenic amino acid homocysteine. (external link)
• Anker, Gun Birgitta; Lønning, Per Eystein; Ueland, Per Magne et al. (1995). Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgitta; Ueland, Per Magne (1995). Pharmacokinetics of tamoxifen in pre- and post-menopausal women with breast cancer. (external link)
• Lønning, Per Eystein; Johannesen, Dag Clement; Helle, Svein Inge et al. (1995). Relations between sex hormones, sex hormone binding globulin insulin-like growth factor binding protein-1 in postmenopausal breast cancer patients. (external link)
• Lønning, Per Eystein; Johannessen, Dag Clement; Lien, Ernst Asbjørn et al. (1995). Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgitta; Lønning, Per Eystein et al. (1995). Determination of droloxifene and two metabolites in serum by high-pressure liquid chromatography. (external link)
• Lønning, Per Eystein; Helle, Svein Inge; Johannessen, Dag Clement et al. (1995). Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgitta; Lønning, Per Eystein et al. (1995). Determination of droloxifene and two metabolites in serum by high pressure liquid chromatography. (external link)
• Anker, Gun Birgitta; Lønning, Per Eystein; Ueland, Per Magne et al. (1995). Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. (external link)
• Lønning, Per Eystein; Helle, Svein Inge; Johannesen, Dag Clement et al. (1995). Influence of tamoxifen on sex hormones, gonadotropins and sex hormone binding globulin in postmenopausal breast cancer patients. (external link)
• Millward, M. J.; Lien, Ernst Asbjørn; Robinson, A. et al. (1994). High-dose (480 mg/day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulator. (external link)
• Lønning, Per Eystein; Lien, Ernst Asbjørn (1994). Pharmacokinetics of anti-endocrine agents. (external link)
• Lønning, Per Eystein; Hall, K.; Aakvaag, A. et al. (1992). Influence of tamoxifen on plasma levels of IGF-I and IGFBP-I in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Johannessen, Dag Clement; Aakvaag, A. et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Johannesen, D. C.; Aakvaag, A. et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
• Lønning, Per Eystein; Hall, K.; Aakvaag, A. et al. (1992). Influence of tamoxifen on plasma levels of insulinelike growth factor I and insulin-like growth factor binding protein I in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Johannessen, Dag Clement; Aakvaag, A. et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
• Milward, M. J.; Cantwell, B. M. J.; Lien, Ernst Asbjørn et al. (1992). Intermittent high dose tamoxifen as a potential modifier of multi-drug resistance. (external link)
• Lien, Ernst Asbjørn; Johannessen, Dag Clement; Aakvaag, A. et al. (1992). Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-1 levels in breast cancer patients. (external link)
• Stuart, N. S. A.; Philip, P.; Harris, A. L. et al. (1992). High dose tamoxifen as an enhancer of etoposide cytotoxicity.Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines. (external link)
• Lønning, Per Eystein; Hall, K.; Aakvaag, A. et al. (1992). Influence of tamoxifen on plasma levels of IGF-I and IGFBP-I in breast cancer patients. (external link)
• Lønning, Per Eystein; Hall, K.; Aakvaag, A. et al. (1992). Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Wester, Knut; Lønning, Per Eystein et al. (1991). Distribution of Tamoxifen and meta-bolites into brain tissue and brain metastases in brain cancer patients. (external link)
• Lien, Ernst Asbjørn; Wester, Knut; Lønning, Per Eystein et al. (1991). Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Solheim, E.; Ueland, P. M. (1991). Distribution of tamoxifen and its metabolites in rat and human tissues during steady state treatment. (external link)
• Lien, Ernst Asbjørn; Wester, Knut; Lønning, Per Eystein et al. (1991). Distribution of tamoxifen and metabolites into brain tissue metastases in breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Solheim, E.; Ueland, P. M. (1991). Distribution of tamoxifen and its metabolites in tissues of rat and man during steady state treatment. (external link)
• Lien, Ernst Asbjørn; Anker, Gun Birgitta; Lønning, Per Eystein et al. (1990). Decreased serum concentrations of tamoxifen and its metabolites induced by aminogluethimide. (external link)

Poster

• Lunde, Siri; Helland, Thomas; Jonassen, Janne et al. (2018). A prospective, longitudinal, breast cancer biobank (PBCB) in western Norway. (external link)
• Christensen, Monika; Nordbø, Yngve; Varhaug, Jan Erik et al. (2013). Vitamin D levels in patients with primary hyperparathyroidism; a follow-up study after parathyroidectomy. (external link)
• Christensen, Monika; Pedersen, Eva Kristine Ringdal; Nordbø, Yngve et al. (2012). Systemic Inflammation in Primary Hyperparathyroidism: Influences on Plasma Vitamin B6 Levels and Interferon-γ Mediated Immune Activation. (external link)
• Christensen, Monika; Dankel, Simon E Nitter; Nordbø, Yngve et al. (2011). Differential Expression of Inflammatory and Metabolic Genes in Adipose Tissue of Patients with Primary Huperparathyroidism. (external link)
• Flågeng, Marianne Hauglid; Moi, Line Leonore Haugan; Gandini, Sara et al. (2010). Expression of Steroid Receptor Coactivators and HER-2/neu in normal and malignant breast tissue in controls and tamoxifen treated patients. (external link)
• Hoang, Tuyen; Fenne, Ingvild Sveinsgjerd; Bergsvåg, Mari et al. (2009). The Role of PKA and CREB in regulation of the Steroid Receptor Coactivator GRIP1/SRC-2. (external link)
• Gjerde, Jennifer; Geisler, Jürgen; Lundgren, Steinar et al. (2009). Relations between FSH, SHBG and tamoxifen metabolism during steady state tamoxifen treatment. (external link)
• Christensen, Monika; Fenne, Ingvild Sveinsgjerd; Flågeng, Marianne Hauglid et al. (2009). PTH inhibits ligand-dependent activation of estrogen receptor alfa in MC3T3 osteoblasts. (external link)
• Flågeng, Marianne Hauglid; Moi, Line Leonore Haugan; Dixon, J. Michael et al. (2009). HER-2/neu and nuclear receptor coactivators are upregulated in breast cancer tumors during estrogen deprivation. (external link)
• Christensen, Monika; Fenne, Ingvild Sveinsgjerd; Flågeng, Marianne Hauglid et al. (2009). PTH inhibits ligand-dependent activation of estrogen receptor alfa in MC3T3 Osteoblasts. (external link)
• Hauglid, Marianne; Moi, Line Leonore Haugan; Dixon, Michael et al. (2008). Changes in mRNA expression levels of steroid receptor coactivators correlate with treatment response to aromatase inhibition in human breast cancer. (external link)
• Gjerde, Jennifer; Geisler, Jurgen; Lundgren, Steinar et al. (2007). A study of association between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferae 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady sate tamoxifen treatment. (external link)
• Gjerde, Jennifer Fernandez; Hauglid, Marianne; Breilid, Harald et al. (2007). Effect of CYP2D6 and SULT1A1 Genotypes on the serum concentration of 4-OHtamoxifen and 4-OH-N-Demethyltamoxifen during steady state treatment of breast cancer patients. (external link)
• Hoang, Tuyen; Fenne, Ingvild Sveinsgjerd; Johannessen, Mona et al. (2006). ROLES OF cAMP RESPONSE ELEMENT BINDING PROTEIN (CREB) IN REGULATION OF GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 (GRIP1). (external link)
• Gjerde, Jennifer; Hauglid, M; Breilid, H et al. (2005). Relationship between CYP2D6 and SULT1A1 genotype and serum concentration of tamoxifen and its metabolites during steady state treatment in breast cancer patients. (external link)
• Gjerde, Jennifer Fernandez; Hauglid, Marianne; Breilid, Harald et al. (2005). Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients. (external link)
• Hoang, Tuyen; Fenne, Ingvild Sveinsgjerd; Lien, Ernst Asbjørn et al. (2005). CHARACTERIZATION OF THE MOLECULAR MECHANISMS BY WHICH THE LEVEL OF NUCLEAR HORMONE RECEPTOR COACTIVATOR GRIP1 IS REGULATED. (external link)
• Moi, Line Leonore Haugan; Kisanga, Elton Richard; Gjerde, Jennifer et al. (2005). Effects of low-dose tamoxifen treatment on expression of drug-metabolising enzymes in rat liver in relation to administration route. (external link)
• Gjerde, Jennifer; Lien, Ernst Asbjørn (2004). Quantification of serum tamoxifen and metabolites by liquid chromatography-tandem mass spectrometry. (external link)
• Moi, Line Leonore Haugan; Kisanga, Elton Richard; Gjerde, Jennifer et al. (2004). Tamoxifen metabolism and induction of hepatic drug-metabolizing enzymes in nude rats. (external link)
• Kisanga, Elton Richard; Gjerde, Jennifer Fernandez; Mellgren, Gunnar et al. (2002). Tamoxifen metabolism in immunocompromised rats and mice. (external link)
• Nedrebø, BG; Ueland, Per Magne; Nygård, O et al. (2001). Plasma levels of homocysteine are changed during treatment of hyper- and hypo-thyroidism. (external link)
• Mellgren, Gunnar; Børud, B; Yri, O et al. (2001). Receptor Interacting Protein RIP140 inhibits transcriptional activity of Steroidogenic factor-1. (external link)
• Lien, Ernst Asbjørn (2001). A comparative study of tamoxifen metabolism in immunodeficient rats and nude mice. (external link)
• Mellgren, Gunnar; Børud, Bente; Yri, Olav Erik et al. (2001). Receptor Interacting Protein RIP140 inhibits transcriptional activity of Steroidogenic factor-1. (external link)
• Mellgren, Gunnar; Børud, Bente; Yri, Olav Erik et al. (2001). Receptor Interacting Protein RIP140 inhibits transcriptional activity of Steroidogenic factor–1. (external link)
• Kisanga, Elton Richard; Mellgren, Gunnar; Lien, Ernst Asbjørn (2001). A comparative study of tamoxifen metabolism in immunodeficient nude rats and nude mice. (external link)

Reader opinion piece

• Søiland, Håvard; Hagen, Kari Britt; Gjerde, Jennifer et al. (2013). Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients. (external link)
• Lien, Ernst Asbjørn; Ueland, Per Magne; Lønning, Per Eystein (2004). Letter. (external link)
• Lien, Ernst Asbjørn; Hustad, Steinar; Nedrebø, Bjørn Gunnar et al. (2001). Total plasma homocysteine in hypo- and hyperthyroidism: Covariations and causality. (external link)

Abstract

• Lien, Ernst Asbjørn; Søiland, Håvard; Gjerde, Jennifer (2013). Associations between tamoxifen and age during steady state tamoxifen treatment of postmenopausal women with breast cancer. (external link)
• Gjerde, Jennifer; Geisler, Jürgen; Lundgren, Steinar et al. (2010). Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism. (external link)
• Methlie, Paal; Løvås, Kristian; Lien, Ernst Asbjørn et al. (2010). Grapefruit and Liquorice Increase Bioavailable Cortisol in Addison's Disease. (external link)
• Decensi, A; Guerrieri-Gonzaga, A; Gandini, S et al. (2009). Ki-67 Expression after Tamoxifen Given Preoperatively Predicts Disease Free Survival and Overall Survival in Women with Operable ER-Positive Breast Cancer. (external link)
• Christensen, Monika; Lien, Ernst Asbjørn; Almås, Bjørg (2008). Vitamin D-metabolism and PTH levels show a biphasic seasonal pattern but are not correlated to osteocalcin levels in outpatients from western Norway. (external link)
• Gjerde, Jennifer Fernandez; Geisler, Jurgen; Lundgren, Steinar et al. (2008). A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment. (external link)
• Gjerde, Jennifer Fernandez; Hauglid, Marianne; Breilid, Harald et al. (2007). Effect of CYP2D6 and SULT1A1 genotypes on the serum concentration of 4-hydroxytamoxifen and 4-hydroxy-N-demethyltamoxifen during steady state treatment of breast cancer patients. (external link)
• Gjerde, Jennifer Fernandez; Geisler, Jurgen; Lundgren, Steinar et al. (2007). A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment. (external link)
• Gjerde, Jennifer Fernandez; Hauglid, Marianne; Breilid, Harald et al. (2005). Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients. (external link)

Academic chapter/article/Conference paper

• Gjerde, Jennifer; Moi, Line Leonore Haugan; Mellgren, Gunnar et al. (2012). Tamoxifen metabolism and biological activity. (external link)
• Moi, Line Leonore Haugan; Flågeng, Marianne Hauglid; Fenne, Ingvild Sveinsgjerd et al. (2011). Steroid Receptor Coactivators and Their Expression, Regulation and Functional Role in Endocrine Responsive and Resistant Breast Cancer. (external link)
• Moi, Line Leonore Haugan; Flågeng, Marianne Hauglid; Dankel, Simon E Nitter et al. (2011). Steroid Receptor Coactivators and Endocrine Treatment in Breast Cancer. (external link)
• Lønning, Per Eystein; Lien, Ernst Asbjørn; Tveter, K et al. (1999). Hormoner og hormonantagonister. (external link)
• Aamo, Trond; Brørs, Odd; Lien, Ernst Asbjørn (1998). Legemiddelanalyser og rusmiddelanalyser. (external link)
• Lien, Ernst Asbjørn (1994). Utprøving av dataprogrammet "Aldus Persuasion" og "Davis Transview Presenter" som hjelpemidler i forberedelse og gjennomføring av undervisning. (external link)
• Lien, Ernst Asbjørn; Wester, Knut; Lønning, Per Eystein et al. (1991). Tamoxifen uptake in brain tissue and brain metastases in man. (external link)

Doctoral dissertation

• Holm, Pål Ivar; Lien, Ernst Asbjørn; Ueland, Per Magne (2007). Betaine and its relation to homocysteine status and one-carbon metabolism in humans : analytical method and biochemical studies. (external link)
• Hoang, Tuyen; Mellgren, Gunnar; Lien, Ernst Asbjørn (2007). Nuclear Receptor Coregulators- Role of Protein-Protein Interactions and cAMP/PKA Signaling. (external link)
• Nedrebø, Bjørn Gunnar; Lien, Ernst Asbjørn (2004). Graves' disease and hypothyroidism with emphasis on treatment, homocysteine and B-vitamins. (external link)
• Kisanga, Elton Richard; Lien, Ernst Asbjørn (2004). Pharmacology of low-dose tamoxifen regimens in breast cancer treatment. (external link)
• Lien, Ernst Asbjørn (1991). Tamoxifen pharmacokinetics in breast cancer patients. Analytical methods, pharmacokinetics, tissue distribution and drug interactions. (dr.med.). (external link)

Academic lecture

• Gjerde, Jennifer Fernandez; Lien, Ernst Asbjørn (2005). Distribution of tamoxifen in serum and breast cancer tissue and its effects on sex hormone-binding globulin (SHBG). (external link)
• Lien, Ernst Asbjørn (2004). Pharmacokinetics and pharmacodynamics of tamoxifen. (external link)
• Mellgren, Gunnar; Børud, Bente; Æsøy, Reidun et al. (2002). Steroidogenesis - Role of Steroidogenic factor-1 and interacting nuclear receptor coregulators. (external link)
• Lien, Ernst Asbjørn (2001). Homocysteine and thyroid function. (external link)
• Ulvik, A; Evensen, Espen Thiis; Lien, Ernst Asbjørn et al. (2001). Smoking, folate, and MTHFR C677T genotype as interactive determinants of adenomatous and hyperplastic polyps of colorectum. (external link)
• Gonzaga, A; Baglietto, L; Johansson, H et al. (2000). Correlation between tamoxifen elimination and biomarker recovery in a promary prevention trial. (external link)
• Nedrebø, Bjørn G; Aanderud, Sylvi; Nygård, Ottar et al. (1999). Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism. (external link)
• Lien, Ernst Asbjørn; Overå, O. (1997). Phase 1 and pharmacokinetic study of high dose tamoxifen combined with epirubicin, cyclophosphamide and oncovin. (external link)

Documentary

• Lien, Ernst Asbjørn (2004). "En hormonell kriminalhistorie". (external link)

See a complete overview of publications in Cristin.